share_log

长药控股(300391.SZ):上半年净亏损1.53亿元

Changjiang Pharmaceutical Group (300391.SZ): The net loss in the first half of the year was 0.153 billion yuan.

Gelonghui Finance ·  Aug 29 09:01

Changjiang Pharmaceutical Group (300391.SZ) announced its 2024 semi-annual report, with revenue for the reporting period of 73.6537 million yuan, a year-on-year decrease of 84.53%; net income attributable to shareholders of listed companies was -0.153 billion yuan, with a widened year-on-year loss; net income attributable to shareholders of listed companies after deducting non-recurring gains and losses was -0.15 billion yuan; basic earnings per share was -0.4355 yuan.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment